Antibody-drug Conjugate and ADC Related

(+)-CBI-CDPI1 - HY-128880

(+)-CBI-CDPI2 - HY-128881

(1-OH)-Exatecan - HY-156642

(1R)-Deruxtecan - HY-13631O

(1R,9R)-Exatecan (mesylate) - HY-13631J

(1S,9R)-Exatecan (mesylate) - HY-13631I

(2-pyridyldithio)-PEG1-hydrazine - HY-136135

(2-pyridyldithio)-PEG4 acid - HY-135964

(2-Pyridyldithio)-PEG6 acid - HY-132086

(2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)butanoic acid - HY-W099352

(2R,3S)-Fmoc-Abu(3-N3)-OH - HY-151734

(2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate - HY-W002680

(2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride - HY-76104

(2R,4R)-Boc-D-Pro(4-N3)-OH - HY-151848

(2R,4R)-Fmoc-D-Pro(4-N3)-OH - HY-151681

(2R,4R)-H-D-Pro(4-N3)-OH (hydrochloride) - HY-151839

(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid - HY-77593

(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate - HY-W017882

(2R,4S)-Boc-D-Pro(4-N3)-OH (DCHA) - HY-151677A

(2R,4S)-Boc-D-Pro(4-N3)-OH - HY-151677

(2R,4S)-Fmoc-D-Pro(4-N3)-OH - HY-151762

(2R,4S)-H-D-Pro(4-N3)-OH (hydrochloride) - HY-151760A

(2R,4S)-H-D-Pro(4-N3)-OH - HY-151760

(2S)-N3-HABA - HY-151866

(2S)-N3-IsoSer (DCHA) - HY-151702A

(2S)-N3-IsoSer - HY-151702

(2S,3R)-Fmoc-Abu(3-N3)-OH - HY-151689

(2S,3R)-H-Abu(3-N3)-OH (hydrochloride) - HY-151836

(2S,3S)-H-Abu(3-N3)-OH (hydrochloride) - HY-151838

(2S,4R)-Fmoc-L-Pro(4-N3)-OH - HY-151850

(2S,4R)-H-L-Pro(4-N3)-OH (hydrochloride) - HY-151639A

(2S,4R)-H-L-Pro(4-N3)-OH - HY-151639

(2S,4S)-Fmoc-L-Pro(4-NHPoc)-OH - HY-151814

(2S,4S)-H-L-Pro(4-N3)-OH (hydrochloride) - HY-151865A

(2S,4S)-H-L-Pro(4-N3)-OH - HY-151865

(4-NH2)-Exatecan - HY-145397

(4-NH2)-Exatecan-d5 - HY-145397S

(4S)​-4-Hydroxy-D-proline methyl ester (hydrochloride) - HY-W006629

(5-Cl)-Exatecan - HY-160806

(Ac)Phe-Lys(Alloc)-PABC-PNP - HY-20560

(Aminooxy)acetamide-Val-Cit-PAB-MMAE - HY-153263

(Me)Tz-butanoic acid - HY-151730

(R)-(4-NH2)-Exatecan - HY-145397A

(R)-8-Azido-2-(Fmoc-amino)octanoic acid - HY-131082

(R)-Azetidine-2-carboxylic acid - HY-W017755

(R)-Benzyl 2-cyclopropyl-2-hydroxyacetate - HY-400708

(R)-DM4-SPDP - HY-126493A

(R)-Exatecan Intermediate 1 - HY-42487B

(R)-Methotrexate-d3 - HY-14519CS

(R)-NODAGA-tris(t-Bu ester) - HY-W591317

(R,E)-TCO-PEG8-acid - HY-141161B

(R,E)-TCO-PEG8-NHS ester - HY-141169B

(rac)-Exatecan Intermediate 1 - HY-42487A

(Rac)-Lys-SMCC-DM1 - HY-101982A

(S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-CH2-Me-PIP-Boc - HY-168076

(S)-DOTAGA.(SA.FAPi)2 - HY-159767A

(S)-EB-FAPI-B2 - HY-159770A

(S)-N3-HABA (DCHA) - HY-151866A

(S)-Seco-Duocarmycin SA - HY-129356A

(S)-TCO-PEG2-Maleimide - HY-157008